Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Asset Utilization Ratio (2016 - 2025)

Viridian Therapeutics, Inc.\DE has reported Asset Utilization Ratio over the past 12 years, most recently at 0.1 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.1 for Q4 2025, up 23959.67% from a year ago — trailing twelve months through Dec 2025 was 0.1 (up 23959.67% YoY), and the annual figure for FY2025 was 0.09, up 17515.83%.
  • Asset Utilization Ratio for Q4 2025 was 0.1 at Viridian Therapeutics, Inc.\DE, down from 0.12 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for VRDN hit a ceiling of 0.12 in Q3 2025 and a floor of 0.0 in Q4 2024.
  • Median Asset Utilization Ratio over the past 5 years was 0.0 (2022), compared with a mean of 0.02.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 92.02% in 2021 and later surged 27344.94% in 2025.
  • Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio stood at 0.01 in 2021, then plummeted by 70.98% to 0.0 in 2022, then crashed by 81.06% to 0.0 in 2023, then plummeted by 47.97% to 0.0 in 2024, then soared by 23959.67% to 0.1 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.1 (Q4 2025), 0.12 (Q3 2025), and 0.0 (Q2 2025) per Business Quant data.